Nanjing Leads Biolabs Co., Ltd. Wins Japan Orphan Drug Status for LBL-024
Nanjing Leads Biolabs said Japan’s MHLW granted Orphan Drug Designation to opamtistomig (LBL-024) for extrapulmonary neuroendocrine carcinoma, adding to prior U.S. and EU ODDs. The company notes potential development and review incentives in Japan.Material DetailsContext by AI AnalystThis extends a…